Latest Diabetes: Type II news
ADA: Retatrutide Improves HbA1c in Inadequately Controlled Type 2 Diabetes
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
ERA: Semaglutide Improves Health-Related QoL in Adults With T2D, CKD
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ERA: Dihydropyridine Calcium-Channel-Blockers Tied to Higher Risk for Kidney Disease Progression in T2D
posted June 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Oral Orforglipron Noninferior, Superior to Oral Semaglutide for T2DM
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
Type 2 Diabetes Linked to Worse Menopausal Symptoms
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes